Boston Partners cut its holdings in shares of Quipt Home Medical Corp. (NASDAQ:QIPT – Free Report) by 61.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 218,820 shares of the company’s stock after selling 352,479 shares during the quarter. Boston Partners’ holdings in Quipt Home Medical were worth $667,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Atom Investors LP purchased a new position in shares of Quipt Home Medical during the third quarter valued at about $51,000. XTX Topco Ltd purchased a new position in shares of Quipt Home Medical during the third quarter valued at about $54,000. JPMorgan Chase & Co. grew its position in shares of Quipt Home Medical by 68.7% during the third quarter. JPMorgan Chase & Co. now owns 30,403 shares of the company’s stock valued at $89,000 after purchasing an additional 12,383 shares in the last quarter. Los Angeles Capital Management LLC purchased a new position in shares of Quipt Home Medical during the fourth quarter valued at about $104,000. Finally, Raymond James Financial Inc. purchased a new position in shares of Quipt Home Medical during the fourth quarter valued at about $113,000. Hedge funds and other institutional investors own 42.85% of the company’s stock.
Insider Buying and Selling
In related news, VP Patrick Dennis Gamble purchased 17,000 shares of the company’s stock in a transaction that occurred on Thursday, December 26th. The stock was bought at an average price of $2.45 per share, for a total transaction of $41,650.00. Following the completion of the transaction, the vice president now owns 40,057 shares in the company, valued at approximately $98,139.65. The trade was a 73.73 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. 13.40% of the stock is currently owned by company insiders.
Quipt Home Medical Trading Up 2.6 %
Quipt Home Medical (NASDAQ:QIPT – Get Free Report) last issued its quarterly earnings data on Monday, February 10th. The company reported ($0.03) earnings per share for the quarter. Quipt Home Medical had a negative net margin of 2.90% and a negative return on equity of 6.70%. Equities research analysts anticipate that Quipt Home Medical Corp. will post -0.05 EPS for the current fiscal year.
About Quipt Home Medical
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Read More
- Five stocks we like better than Quipt Home Medical
- How to Evaluate a Stock Before BuyingÂ
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Where to Find Earnings Call Transcripts
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- What is Put Option Volume?
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Want to see what other hedge funds are holding QIPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quipt Home Medical Corp. (NASDAQ:QIPT – Free Report).
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.